Mitchell J. Silver, D.O., FACC,
FSVM, RPVI, a renowned interventional cardiologist and vascular
medicine specialist, is the company's new Chief Medical Officer
(CMO). He will guide clinical development, regulatory affairs, and
commercialization efforts for the upcoming launch of the Neuroguard
IEP® System carotid stent delivery catheter, Neuroguard IEP Direct
transcarotid revascularization system, and Excipio® peripheral
thrombectomy devices.
RALEIGH,
N.C., Aug. 5, 2024 /PRNewswire-PRWeb/ -- Contego
Medical, Inc. announced today that Mitchell
J. Silver, D.O., FACC, FSVM, RPVI, a renowned interventional
cardiologist and vascular medicine specialist, joined the team as
Chief Medical Officer (CMO). He will play a pivotal role in shaping
the company's clinical strategy and advancing the portfolio of
carotid and thrombectomy products. His medical leadership and
strategic guidance will help guide clinical development, regulatory
affairs, and commercialization efforts for the upcoming launch of
the Neuroguard IEP® System carotid stent delivery catheter,
Neuroguard IEP Direct transcarotid revascularization system, and
Excipio® peripheral thrombectomy devices.
Dr. Silver is a visionary in the
cardiovascular space. He has been involved in the treatment of
carotid and peripheral vascular disease for many years. Hie
experience and dedication to advancing medical research prepared
him to make a significant impact at Contego Medical.
Dr. Silver brings extensive experience in cardiovascular and
vascular medicine and specializes in managing arterial, venous, and
lymphatic diseases. Before joining Contego Medical, he was at
OhioHealth Heart and Vascular Physicians in Columbus, Ohio, where he was the Director of
the Center for Critical Limb Care and Endovascular Research. Dr.
Silver founded the Cornwell Center for Cardiovascular and Diabetes
Care at Ohio University. His
contributions to the field include over 100 peer-reviewed
manuscripts and book chapters on carotid artery atherosclerosis,
peripheral vascular disease, and venous thromboembolism.
He has been a proponent of carotid artery stenting since the
mid-1990s and contributed to research efforts to develop the first
embolic protection device. Dr. Ravish Sachar, Contego Medical's CEO
and Founder, stated, "Dr. Silver is a visionary in the
cardiovascular space. He has been deeply involved in the treatment
of carotid and peripheral vascular disease for many years, and his
experience and dedication to advancing medical research prepared
him to make a significant impact here. He is uniquely suited for
the role of Contego's CMO, and we are very excited and honored that
he will be joining Contego full-time."
Over the past decade, Dr. Silver's research focused on deep vein
thrombosis (DVT) and pulmonary embolism. He served as the national
principal investigator (PI) for the FLAME study, the largest
prospective study of interventional treatment in high-risk
pulmonary embolism and co-principal investigator of CLEAR DVT, an
international study on acute deep venous thrombosis management.
Dr. Silver's collaboration with Contego Medical dates back to
the company's inception. He served on the company's board in the
early days. "Joining Contego brings my career full circle, and I am
energized to join the team at this important time in the company's
trajectory," he said.
About Contego Medical
Contego Medical, Inc. is the leader in developing
state-of-the-art solutions that transform complex cases into
simplified procedures. The company's portfolio of integrated,
multi-functional products is designed to improve patient outcomes
and procedural efficiency in the treatment of carotid and
peripheral vascular disease. More than 3,000 patients have been
treated with Contego Medical products to date.
The patented Neuroguard IEP System is currently limited by
Federal U.S. law to investigational use only in the PERFORMANCE II
study (NCT04201132). The Neuroguard IEP Direct System is currently
limited by Federal U.S. law to investigational use only in the
PERFORMANCE III study (NCT05845710).
Paladin, Neuroguard IEP, Vanguard IEP, Excipio, Integrated
Embolic Protection, and FlexRing are trademarks or registered
trademarks of Contego Medical.
Media Contact
Julie Dye, Contego Medical, 1
5125637261, julie@marketingdx.com
View original
content:https://www.prweb.com/releases/dr-mitchell-j-silver-joins-contego-medical-as-chief-medical-officer-302213981.html
SOURCE Contego Medical